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1. INTRODUCTION {#ags312208-sec-0001}
===============

Gastric cancer is the fifth most common malignancy and the third leading cause of cancer death in the world.[1](#ags312208-bib-0001){ref-type="ref"} Although various new drugs have been developed for its treatment, surgically curative resection is still the mainstay of treatment for gastric cancer. Since the first laparoscopic gastrectomy case was reported in 1991,[2](#ags312208-bib-0002){ref-type="ref"} it has gained widespread global popularity owing to laparoscopic hemostatic surgical devices and the standardization of techniques. Several randomized controlled trials (RCT) comparing laparoscopic distal gastrectomy (LDG) with conventional open distal gastrectomy (ODG) have reported superiority in the short‐term advantages for LDG.[3](#ags312208-bib-0003){ref-type="ref"}, [4](#ags312208-bib-0004){ref-type="ref"}, [5](#ags312208-bib-0005){ref-type="ref"}, [6](#ags312208-bib-0006){ref-type="ref"}, [7](#ags312208-bib-0007){ref-type="ref"}, [8](#ags312208-bib-0008){ref-type="ref"}, [9](#ags312208-bib-0009){ref-type="ref"}, [10](#ags312208-bib-0010){ref-type="ref"} Although RCT are ongoing in both Japan and Korea (JCOG0912[11](#ags312208-bib-0011){ref-type="ref"} and KLASS01[12](#ags312208-bib-0012){ref-type="ref"}), several large‐scale retrospective studies have shown acceptable prognostic results of LDG for patients with early gastric cancer.[13](#ags312208-bib-0013){ref-type="ref"}, [14](#ags312208-bib-0014){ref-type="ref"}, [15](#ags312208-bib-0015){ref-type="ref"}, [16](#ags312208-bib-0016){ref-type="ref"}, [17](#ags312208-bib-0017){ref-type="ref"} In recent years, LDG has been implemented in patients with advanced gastric cancer at high‐volume centers, and RCT comparing the feasibility and long‐term survival between LDG and ODG are currently ongoing in China (CLASS‐01 trial[18](#ags312208-bib-0018){ref-type="ref"}), Korea (KLASS‐02 trial[19](#ags312208-bib-0019){ref-type="ref"}), and Japan (JLSSG0901[20](#ags312208-bib-0020){ref-type="ref"}).

In contrast, laparoscopic total gastrectomy (LTG) is not common compared with LDG, which is carried out in only 25% (1556/6183) of total gastrectomy procedures, according to a questionnaire‐based survey conducted by the Japan Society of Endoscopic Surgery in 2015, although the proportion of LDG had increased to 54% (6884/12 722).[21](#ags312208-bib-0021){ref-type="ref"} In this survey, the conversion rate in LTG was reported as 2.1% which was about three times as compared with 0.6% in LDG. Furthermore, according to the National Clinical Database (NCD), covering 95% of general surgery procedures in all of Japan, LTG is carried out in 18% (5749/32 144) of total gastrectomy procedures.[22](#ags312208-bib-0022){ref-type="ref"}

Several reports have already published data on the feasibility and safety of LTG, but these reports were mainly from high‐volume centers, and almost all the LTG were carried out by surgeons who were already accustomed to laparoscopic gastrectomy. Many surgeons still hesitate to carry out LTG, and the main reasons are difficulty of lymphadenectomy at the splenic hilum and the high technical demands of esophagojejunostomy (EJS).

Two large‐scale reports based on data from the National Clinical Database, one retrospective[22](#ags312208-bib-0022){ref-type="ref"} and the other prospective,[23](#ags312208-bib-0023){ref-type="ref"} have been recently reported as so‐called "real‐world data" in Japan, with controversial results about the occurrence of anastomosis‐related complications.

In this article, the status of LTG was reviewed focusing on lymphadenectomy and reconstruction.

2. LYMPHADENECTOMY {#ags312208-sec-0002}
==================

Lymphadenectomy, excision of the regional lymph nodes (LN) draining from a tumor, is an essential element in the surgical management of gastric cancer. The extent of systematic lymphadenectomy is defined, respectively, for each type of gastrectomy, according to Japanese gastric cancer treatment guidelines.[24](#ags312208-bib-0024){ref-type="ref"} In principle, D1 and D1 + lymphadenectomy is indicated for early gastric cancer, and D2 lymphadenectomy for advanced gastric cancer and cases with apparent metastasis at the regional lymph nodes, even in early gastric cancers. In D1 + lymph node dissection, differences between LDG and LTG are only left paracardial LN (No. 2), left greater curvature LN along the short gastric arteries (No. 4sa) which is usually easily removed with the stomach in LTG, and proximal splenic artery LN (No. 11p) which is generally removed in LDG for early gastric cancer. In that sense, technical aspects of lymph node dissection in LTG are like those in LDG for early gastric cancer; therefore, the prognostic evidence based on results of RCT (JCOG 0912), which confirm that LDG is not inferior to ODG in efficacy for early gastric cancer, would be applicable to LTG.

However, LTG for advanced gastric cancer requires precise lymph node dissection. As for LDG, two RCT, JLSSG0901 and KLASS‐02, are in progress and the results will soon be available; they compare long‐term outcomes of LDG with those of ODG. In contrast, although some retrospective studies have reported that long‐term outcome of LTG is equivalent to that of open total gastrectomy (OTG), RCT in LTG for advanced gastric cancer has just been started in Korea (KLASS‐06).

Among several LN stations, splenic hilar (No. 10) and along the distal splenic artery (No. 11d), the LN are specific and are the most applicable regions for the procedure of LTG for advanced gastric cancers. Survival benefit of lymphadenectomy for these regions remains controversial not only for laparoscopic surgery, but also for open surgery of advanced gastric cancer.

The difficulty of lymphadenectomy of the region is due to anatomical variation of the splenic hilar vessels and the narrow and deep space, and lymphadenectomy increases the risks of operative morbidities including pancreatic fistula. In recent reports, the incidence of pancreatic fistula in LTG ranged between 0.2% and 2.7% and this rate is equivalent to OTG.[22](#ags312208-bib-0022){ref-type="ref"}, [23](#ags312208-bib-0023){ref-type="ref"}, [25](#ags312208-bib-0025){ref-type="ref"}, [26](#ags312208-bib-0026){ref-type="ref"} Furthermore, some reports[22](#ags312208-bib-0022){ref-type="ref"}, [25](#ags312208-bib-0025){ref-type="ref"} showed that the incidence of overall complications of LTG was equivalent to that of OTG, and other reports showed that the rate of complications was lower for LTG than for OTG.[23](#ags312208-bib-0023){ref-type="ref"}, [26](#ags312208-bib-0026){ref-type="ref"}, [27](#ags312208-bib-0027){ref-type="ref"} One of the reasons for this is the improvement of energy devices, which is described in many reports,[28](#ags312208-bib-0028){ref-type="ref"}, [29](#ags312208-bib-0029){ref-type="ref"} and some researchers reported that preoperative assessment of splenic vascular anatomy using computed tomography (CT) with 3‐D imaging was useful and correlated with shorter operative time, lower blood loss,[30](#ags312208-bib-0030){ref-type="ref"} and a larger number of retrieved lymph nodes.[31](#ags312208-bib-0031){ref-type="ref"}

Open total gastrectomy with splenectomy has been standard in Japan for complete removal of lymph nodes at the splenic hilum. Splenectomy can be done safely even in laparoscopic surgery by experienced surgeons, and the procedure itself is feasible with good short‐term outcomes.[32](#ags312208-bib-0032){ref-type="ref"}, [33](#ags312208-bib-0033){ref-type="ref"}, [34](#ags312208-bib-0034){ref-type="ref"} Several recent retrospective reports, however, showed that splenectomy in open total gastrectomy could increase postoperative morbidity and mortality[35](#ags312208-bib-0035){ref-type="ref"}, [36](#ags312208-bib-0036){ref-type="ref"} without survival benefit.[37](#ags312208-bib-0037){ref-type="ref"}, [38](#ags312208-bib-0038){ref-type="ref"} In 2017, a multi‐institutional RCT comparing splenectomy with spleen preservation in proximal gastric cancer was conducted in Japan.[39](#ags312208-bib-0039){ref-type="ref"} Splenectomy was associated with higher morbidity and greater blood loss, but had no survival benefit. The RCT concluded that prophylactic splenectomy, even in open surgery, should be avoided not only for operative safety but also for survival benefit, except for cases with tumors invading the greater curvature and with Borrmann type 4 tumors (linitis plastica).

Conversely, the clinical significance of lymph node dissection for cases with tumors invading the greater curvature and type 4 advanced gastric cancer remains a matter of debate. We reported that patients with tumors localized on the greater curvature and type 4 cancer might obtain relatively high survival benefits from splenic hilar lymph node dissection.[40](#ags312208-bib-0040){ref-type="ref"} Son et al[41](#ags312208-bib-0041){ref-type="ref"} reported long‐term results of patients with splenic hilar lymph node metastasis treated by splenectomy (n = 258) or spleen‐preserving hilar lymph node dissection (n = 344). They compared the therapeutic index of splenic hilar lymph node dissection to that for LN dissection at other extraperigastric lymph nodes, such as anterosuperior LN along the common hepatic artery (No. 8a), celiac artery LN (No. 9) etc., and they demonstrated that both therapeutic efficacies were similar. From these findings, Son et al advocated that splenic hilar lymph node dissection is necessary to improve prognosis.

The only certainty at this point is that some patients may receive prognostic benefit from adequate splenic hilar lymph node dissection. Some experienced surgeons have reported laparoscopic techniques of spleen‐preserving splenic hilum lymphadenectomy (SPSL). Uyama et al[42](#ags312208-bib-0042){ref-type="ref"} first introduced a hand‐assisted technique for complicated SPSL. Most surgeons still adopt the suprapancreatic approach, and some experienced surgeons have reported improved techniques for SPSL with some modifications. Mou et al[43](#ags312208-bib-0043){ref-type="ref"} developed a modified approach (combined supra‐ and infra‐pancreatic approaches), and Huang et al[44](#ags312208-bib-0044){ref-type="ref"} developed a surgical procedure by following the perigastric fascia and the intrafascial space according to the embryological and anatomical background. They advocated that the new, safer approaches enabled exposure and dissection of splenic hilum lymph nodes in an approach posterior to the splenic artery. By several techniques described above, most articles have indicated that a laparoscopic approach could also obtain similar short‐term results concerning the number of retrieved splenic hilar lymph nodes and occurrence rates of postoperative complications. Further large‐scale study should be conducted to establish the clinical significance of splenic hilar lymph node dissections.

3. RECONSTRUCTIONS {#ags312208-sec-0003}
==================

In 1999, Azagra et al[45](#ags312208-bib-0045){ref-type="ref"} reported the first case of EJS reconstruction carried out by small laparotomy after LTG. Some other reports have demonstrated good short‐term results after EJS with circular stapler (CS) carried out through a small incision.[46](#ags312208-bib-0046){ref-type="ref"}, [47](#ags312208-bib-0047){ref-type="ref"}, [48](#ags312208-bib-0048){ref-type="ref"} However, inserting and fixing the anvil head into the esophageal stump is sometimes difficult in a narrow and deep operative field. Safe and secure anastomosis is difficult to carry out, requiring careful attention to avoid intervening in surrounding tissues between the anastomotic plane, especially in obese patients. Several intracorporeal EJS techniques have been developed as appropriate laparoscopic reconstruction methods after total gastrectomy. The techniques can be divided into two categories: those using a CS, and those using a linear stapler (LS).

A great advantage of the CS method is its familiarity in conventional open total gastrectomy. There are some other advantages of the CS method compared with the LS method, including no need for intracorporeal suturing procedures and longer trimming of the esophagus. In contrast, advantages of the LS method include better visual field during anastomosis and adaptability for intramediastinal anastomosis in cases with esophageal invasion.

Umemura et al[49](#ags312208-bib-0049){ref-type="ref"} reviewed 254 cases of the CS method and 729 cases of the LS method. They reported that the CS method was significantly associated with high rates of leakage (4.7% vs 1.1%, *P* \< 0.001) and stenosis (8.3% vs 1.8%, *P* \< 0.001) when compared with the LS method. However, the authors discussed that the complication rates partially depended on the experience of the surgeons. Inokuchi et al[50](#ags312208-bib-0050){ref-type="ref"} reviewed anastomotic complications in 46 case studies of LTG to compare various procedures for EJS. They classified anastomosis into six categories: (i) extracorporeal reconstruction by a single‐stapling technique using a CS; (ii) intracorporeal reconstruction by a single‐stapling technique using a CS; (iii) intracorporeal reconstruction by a double (or hemi‐double) stapling technique using a CS with a transabdominally inserted anvil; (d) intracorporeal reconstruction by a double (or hemi‐double) stapling technique using a CS with a transorally inserted anvil (Orvil, Medtronic plc, Dublin, Ireland); (e) intracorporeal reconstruction by side‐to‐side anastomosis using an LS; and (f) intracorporeal reconstruction by functional end‐to‐end anastomosis using LS. Inokuchi and colleagues reported that the incidence of EJS leakage was similar (1.1%‐3.2%), although the incidence of EJS stenosis was relatively high when the OrVil device was used (8.8%) compared with other procedures (1.0%‐3.6%). They discussed the use of a small anvil in some cases for easy passage through the esophageal entrance as the presumed cause of high rates of stenosis. Kyogoku et al[51](#ags312208-bib-0051){ref-type="ref"} reported that there was no difference in the postoperative complication rates related to the type of stapler when surgeons accredited through the Endoscopic Surgical Skill Qualification System of the Japanese Society of Endoscopic Surgery carried out EJS. The authors concluded that determination of the EJS procedure should be selected by preference and experience of the surgeon.

In Table [1](#ags312208-tbl-0001){ref-type="table"}, literature that compares two anastomosis methods in a single institution is shown.[51](#ags312208-bib-0051){ref-type="ref"}, [52](#ags312208-bib-0052){ref-type="ref"}, [53](#ags312208-bib-0053){ref-type="ref"}, [54](#ags312208-bib-0054){ref-type="ref"}, [55](#ags312208-bib-0055){ref-type="ref"}, [56](#ags312208-bib-0056){ref-type="ref"} Five of the studies reported that morbidity such as anastomotic leakage and stricture were not significantly different in CS and LS methods; however, one report showed that the LS method has fewer complications.

###### 

Summary reported comparing circular stapler and linear stapler after total gasrectomy in same institution

  Authors           No. of patients   Stapler   Method                   Mean operative time (min)                     Mean blood loss (ml)                          Morbidity (%)                                 Leakage rate (%)   Stricture rate (%)                            Mortality (%)   LOH (day)                                    Year
  ----------------- ----------------- --------- ------------------------ --------------------------------------------- --------------------------------------------- --------------------------------------------- ------------------ --------------------------------------------- --------------- -------------------------------------------- ------
  Kim EY^52^        29                CS        mini‐laparotomy          230.3                                         106.3                                         17.2                                          0                  3.4                                           0               9.7                                          2016
                    27                LS        linear                   228.9                                         90.9                                          18.5                                          3.7                0                                             0               13.6                                         
  Kawamura H^53^    49                CS        Orvil                    259.5                                         53.3                                          8.2[a](#ags312208-note-0003){ref-type="fn"}   4.1                4.1[a](#ags312208-note-0003){ref-type="fn"}   NA              NA                                           2017
                    139               LS        overlap                  276.5                                         69.7                                          0.7[a](#ags312208-note-0003){ref-type="fn"}   0.7                0[a](#ags312208-note-0003){ref-type="fn"}     NA              NA                                           
  Gong CS^54^       266               CS        mini‐laparotomy          170                                           NA                                            NA                                            5.6                1.1                                           NA              7                                            2017
                    421               LS        FEEA                     149                                           NA                                            NA                                            3.6                0.5                                           NA              6.8                                          
  Yasukawa D^55^    51                CS        Orvil                    346.1                                         34                                            9.8                                           3.9                0                                             0               13.0                                         2017
                    18                LS        FEEA                     348.4                                         35                                            5.6                                           0                  5.6                                           0               12.0                                         
  Kyogoku N^51^     83                CS        Orvil or mini‐lapatomy   330[a](#ags312208-note-0003){ref-type="fn"}   100[a](#ags312208-note-0003){ref-type="fn"}   25                                            4.0                7.0                                           NA              10[a](#ags312208-note-0003){ref-type="fn"}   2018
                    208               LS        FEEA or overlap          297[a](#ags312208-note-0003){ref-type="fn"}   23[a](#ags312208-note-0003){ref-type="fn"}    20                                            1.0                5.0                                           NA              13[a](#ags312208-note-0003){ref-type="fn"}   
  Yoshikawa K^56^   36                CS        Orvil                    345[a](#ags312208-note-0003){ref-type="fn"}   45[a](#ags312208-note-0003){ref-type="fn"}    13.9                                          0                  8.3                                           2.8             17.2                                         2018
                    47                LS        overlap                  398[a](#ags312208-note-0003){ref-type="fn"}   126[a](#ags312208-note-0003){ref-type="fn"}   10.6                                          4.3                0                                             0               19.5                                         

CS, circular stapler; FEEA, functional end?to?end anastomosis; LS, linear stapler; LOH, length of hospital stay; NA, not available.

Orvil, Medtronic plc, Dublin, Ireland.

*P* \< 0.05

John Wiley & Sons, Ltd

4. LINEAR STAPLER {#ags312208-sec-0004}
=================

Esophagojejunostomy using LS is mainly divided into two types; a functional end‐to‐end anastomosis (FEEA) and a side‐to‐side anastomosis (called the "overlap method").

Uyama et al[57](#ags312208-bib-0057){ref-type="ref"} first reported EJS using LS by a completely intra‐abdominal approach. Since then, the required knowledge and skills for the FEEA procedure have been reported in several papers. Although this method is simple, sufficient mobilization of the esophageal stump and the jejunal limb is required to reduce tension at the anastomotic site. Furthermore, side‐to‐side anastomosis is occasionally difficult as a result of the peri‐hiatal restricted space, especially in proximal cancer with esophageal invasion and esophagogastric junction cancer. Based on these weaknesses, Inaba et al[58](#ags312208-bib-0058){ref-type="ref"} reported another side‐to‐side anastomosis method called the "overlap method". Furthermore, in recent years, several modified procedures of the overlap method have been reported. Nagai et al[59](#ags312208-bib-0059){ref-type="ref"} made the anastomosis in an inverted T‐shape to prevent the anastomosis from slipping into the mediastinum. Yamamoto et al[60](#ags312208-bib-0060){ref-type="ref"} transected the esophagus while being rotated by 90 degrees, making suturing of the entry hole easier. In either method, a 45‐mm cartridge is usually used in the anastomosis of the LS, and there is an advantage that the anastomosis diameter can be made larger as compared with the EJS using a CS.

Many papers have reported the safety and feasibility of EJS conducted by LS. However, the need for suturing technique and enough mobilization of the esophageal stump may sometimes cause nonexpert laparoscopic surgeons to hesitate about introducing EJS using the LS. Recent development and application of a barbed absorbable closure device (V‐Loc; Medtronic plc, Dublin, Ireland) may eliminate the hesitation about hand‐sewn suturing.[61](#ags312208-bib-0061){ref-type="ref"}

Interestingly, esophageal hiatal hernia has recently been reported as a postoperative complication of EJS using LS after LTG. Ito et al[62](#ags312208-bib-0062){ref-type="ref"} reported that postoperative esophageal hiatal hernia occurred in seven (9%) of 78 patients who underwent LTG for gastric cancer, and all of them were patients who had an incision in the diaphragm. They concluded that when the crus was incised to improve the visual field of the anastomosis, it should have been repaired.

5. CIRCULAR STAPLER {#ags312208-sec-0005}
===================

As described above, many surgeons are familiar with reconstruction methods using the CS. Therefore, the CS method has been more widespread than the LS method, especially in the introductory period. Since the transorally inserted anvil (OrVil) was developed, it is easier and very convenient to carry out intracorporeal EJS and esophagogastrostomy. Several reports have reported the safety and feasibility of EJS carried out by the CS method in LTG.[63](#ags312208-bib-0063){ref-type="ref"} However, some papers noted a high incidence of postoperative complications in CS methods.

For this paper, a literature retrieval was carried out in PubMed for January 1, 1997 through April 30, 2018. The search terms included "laparoscopic," "total gastrectomy," and "gastric cancer." Reports in languages other than English, reviews, and meta‐analyses were excluded, and cases \<10 were also excluded.

We reviewed anastomotic complications, especially those reported on leakage and stricture, in 43 extracted studies of LTG.^33,46,48,52--56,63--97^ We compared the surgical results of various anastomotic procedures for EJS using the CS, with attention to the insertion procedure of the anvil and the insertion site of the anastomotic device.

First, the insertion procedure of the anvil was classified into the following three categories: (i) single‐stapling technique (SST) using hand‐sewn purse‐string suture or purse‐string instrument (PSI); (ii) double‐stapling technique (DST)/hemi‐double‐stapling technique (HDST) with transabdominally inserted anvil; or (iii) DST/HDST with transorally inserted anvil (OrVil) (Table [2](#ags312208-tbl-0002){ref-type="table"}).

###### 

Summary reported of esophagojejnostomy methods after laparoscopic total gastrectomy for gastric cancer n (%)

  Authors                                                 Nation           Method           No. of patients   Morbidity                                          Leakage    Stricture                                           Year
  ------------------------------------------------------- ---------------- ---------------- ----------------- -------------------------------------------------- ---------- --------------------------------------------------- ------
  1\) SST                                                                                                                                                                                                                       
  Usui S^64^                                              Japan            PSI              15                NA                                                 0 (0)      0 (0)                                               2008
  Kinoshita T^65^                                         Japan            hand‐sewn        10                NA                                                 0 (0)      0 (0)                                               2010
  Lee JH^33^                                              South Korea      PSI              79                NA                                                 2 (2.5)    0 (0)                                               2012
  Shim JH^66^                                             South Korea      hand‐sewn        12                NA                                                 2 (17)     5 (42)                                              2013
  Kim HI^67^                                              South Korea      hand‐sewn        36                NA                                                 0 (0)      0 (0)                                               2013
  Yoshikawa T^68^                                         Japan            hand‐sewn        20                NA                                                 0 (0)      0 (0)                                               2013
  Du J^69^                                                China            hand‐sewn        52                NA                                                 0 (0)      0 (0)                                               2014
  Matsuda T^70^                                           Japan            hand‐sewn        21                3 (14.3)                                           1 (4.8)    1 (4.8)                                             2015
  Kosuga T^71^                                            Japan            hand‐sewn        65                11 (16.9)                                          2 (3.1)    4 (6.2)                                             2015
  Yamada T^73^                                            Japan            hand‐sewn        10                0 (0)                                              0 (0)      0 (0)                                               2015
  Chen K^72^                                              China            hand‐sewn        18                5 (27.8)                                           1 (5.6)    1 (5.6)                                             2016
  Amisaki M^74^                                           Japan            PSI              10                NA                                                 0 (0)      0 (0)                                               2016
  Kim EY^52^                                              South Korea      hand‐sewn        29                5 (17.2)                                           0 (0)      1 (3.4)                                             2016
  Gong CS^54^                                             South Korea      minilapatomy     266               74 (27.8)                                          15 (5.6)   3 (1.1)                                             2017
  Okuno K^75^                                             Japan            PSI              94                NA                                                 0 (0)      2 (2.1)                                             2017
  Liu W^76^                                               China            PSI              41                NA                                                 0 (0)      0 (0)                                               2017
  Total                                                   778                               23 (3.0)          17 (2.2)[a](#ags312208-note-0006){ref-type="fn"}                                                                  
  2\) DST/HDST with trans‐abdominally inserted anvil                                                                                                                                                                            
  Omori T^77^                                             Japan            HDST             10                NA                                                 0 (0)      0 (0)[a](#ags312208-note-0006){ref-type="fn"}       2009
  Muguruma K^78^                                          Japan            HDST             32                NA                                                 0 (0)      0 (0)[a](#ags312208-note-0006){ref-type="fn"}       2014
  Zhao YL^79^                                             China            HDST             26                NA                                                 0 (0)      0 (0)[a](#ags312208-note-0006){ref-type="fn"}       2014
  Kim JH^80^                                              South Korea      DST              58                8 (13.8)                                           0 (0)      1 (1.7)[a](#ags312208-note-0006){ref-type="fn"}     2015
  Ichikawa D^63^                                          Japan            HDST (lift up)   58                9 (15.5)                                           0 (0)      2 (3.4)[a](#ags312208-note-0006){ref-type="fn"}     2015
  Wang H^81^                                              China            HDST             42                NA                                                 1 (2.4)    2 (4.8)[a](#ags312208-note-0006){ref-type="fn"}     2015
  Kosuga T^71^                                            Japan            HDST (lift up)   71                23 (32.4)                                          7 (9.9)    13 (18.3)[a](#ags312208-note-0006){ref-type="fn"}   2015
  Ali B^82^                                               South Korea      HDST             58                NA                                                 3 (5.2)    5 (8.6)[a](#ags312208-note-0006){ref-type="fn"}     2017
  Li X^83^                                                China            HDST             24                3 (12.5)                                           1 (4.2)    0 (0)[a](#ags312208-note-0006){ref-type="fn"}       2017
  Total                                                   379                               12 (3.2)          23 (6.1)[a](#ags312208-note-0006){ref-type="fn"}                                                                  
  3\) DST/HDST with trans‐orally inserted anvil (Orvil)                                                                                                                                                                         
  Jeong O^84^                                             South Korea      Orvil            16                NA                                                 0 (0)      0 (0)[a](#ags312208-note-0006){ref-type="fn"}       2009
  Sakuramoto S^85^                                        Japan            Orvil            24                NA                                                 0 (0)      0 (0)[a](#ags312208-note-0006){ref-type="fn"}       2010
  Kachikwu EL^86^                                         United States    Orvil            16                NA                                                 0 (0)      3 (18.8)[a](#ags312208-note-0006){ref-type="fn"}    2011
  Kunisaki C^46^                                          Japan            Orvil            30                2 (6.7)                                            1 (3.3)    0 (0)[a](#ags312208-note-0006){ref-type="fn"}       2011
  Marangoni G^87^                                         United Kingdom   Orvil            13                NA                                                 0 (0)      0 (0)[a](#ags312208-note-0006){ref-type="fn"}       2012
  Jung YJ^48^                                             South Korea      Orvil            40                NA                                                 2 (5)      1 (2.5)[a](#ags312208-note-0006){ref-type="fn"}     2013
  Liao GQ^88^                                             China            Orvil            21                NA                                                 1 (4.8)    1 (4.8)[a](#ags312208-note-0006){ref-type="fn"}     2013
  Shim JH^66^                                             South Korea      Orvil            12                NA                                                 2 (17)     4 (33)[a](#ags312208-note-0006){ref-type="fn"}      2013
  Xie JW^89^                                              China            Orvil            28                NA                                                 0 (0)      0 (0)[a](#ags312208-note-0006){ref-type="fn"}       2013
  Zuiki T^90^                                             Japan            Orvil            52                NA                                                 1 (1.9)    11 (21)[a](#ags312208-note-0006){ref-type="fn"}     2013
  Lafemina J^91^                                          United States    Orvil            17                NA                                                 1 (5.9)    1 (5.9)[a](#ags312208-note-0006){ref-type="fn"}     2013
  Hiyoshi Y^92^                                           Japan            Orvil            21                NA                                                 2 (9.5)    0 (0)[a](#ags312208-note-0006){ref-type="fn"}       2014
  Ito H^93^                                               Japan            Orvil            117               NA                                                 2 (1.7)    2 (1.7)[a](#ags312208-note-0006){ref-type="fn"}     2014
  Kwon Y^94^                                              South Korea      Orvil            36                20 (55.6)                                          1 (2.8)    2 (5.7)[a](#ags312208-note-0006){ref-type="fn"}     2014
  Wang H^81^                                              China            Orvil            42                NA                                                 0 (0)      2 (4.8)[a](#ags312208-note-0006){ref-type="fn"}     2015
  Ichikawa D^63^                                          Japan            Orvil            28                5 (17.9)                                           0 (0)      1 (3.6)[a](#ags312208-note-0006){ref-type="fn"}     2015
  Lu X^95^                                                China            Orvil            25                7 (28.0)                                           0 (0)      0 (0)[a](#ags312208-note-0006){ref-type="fn"}       2016
  Brenkman HJ^96^                                         Nertherlands     Orvil            47                24 (51.1)                                          6 (12.8)   11 (23)[a](#ags312208-note-0006){ref-type="fn"}     2016
  Shida A^97^                                             Japan            Orvil            100               11 (11.0)                                          4 (4.0)    4 (4)[a](#ags312208-note-0006){ref-type="fn"}       2016
  Yasukawa D^55^                                          Japan            Orvil            51                5 (9.8)                                            2 (3.9)    0 (0)[a](#ags312208-note-0006){ref-type="fn"}       2017
  Kawamura H^53^                                          Japan            Orvil            49                4 (8.2)                                            2 (4.1)    2 (4.1)[a](#ags312208-note-0006){ref-type="fn"}     2017
  Li X^83^                                                China            Orvil            19                1 (5.3)                                            0 (0)      1 (5.3)[a](#ags312208-note-0006){ref-type="fn"}     2017
  Yoshikawa K^56^                                         Japan            Orvil            36                5 (13.9)                                           0 (0)      3 (8.3)[a](#ags312208-note-0006){ref-type="fn"}     2018
  Total                                                   840                               27 (3.2)          49 (5.8)[a](#ags312208-note-0006){ref-type="fn"}                                                                  

DST, double?stapling technique; HDST, hemi?double stapling technique; NA, not available; PSI, purse?string suture instrument; SST, single?stapling technique.

Orvil, Medtronic plc, Dublin, Ireland.

*P* \< 0.05 (Chi‐square test)

John Wiley & Sons, Ltd

No significant differences were found in these three categories in the frequency of anastomotic leakage. However, the rate of anastomotic stricture was the lowest in SST and the highest in DST/HDST with a transabdominally inserted anvil.

Comparing this result with the review by Inokuchi et al,[50](#ags312208-bib-0050){ref-type="ref"} our results showed that the occurrence of anastomotic stricture was equivalent in cases of SST reconstruction (2.2% and 2.1%, respectively); however, the incidence rate was lower than that of results in OrVil reconstruction (5.8% and 8.8%, respectively). Standardization of the procedures and recognition of necessary skills for reconstruction using OrVil, including minimization of a small incision through which the tube is pulled out and tension‐free anastomosis, may have contributed to the recent reduction of anastomotic stricture.

In principle, the success of reconstruction mainly depends on sufficient blood supply and tension‐free anastomosis. For sufficient blood supply, the length of detachment from the esophageal stump should be the minimum required for EJS anastomosis. For anastomotic tension, Okata reported that anastomosis under tension significantly increases anastomotic complications.[98](#ags312208-bib-0098){ref-type="ref"} Some efforts to decrease the tension, such as dissecting a marginal artery of the jejunal artery, sacrificing the jejunum,[99](#ags312208-bib-0099){ref-type="ref"} and elevating the jejunum through the retrocolic route, should be considered during the operation in the case of EJS under tension.

Next, all of the studies retrieved above were summarized according to the insertion site of the suture instrument, such as left upper, left lower, and umbilical (Table [3](#ags312208-tbl-0003){ref-type="table"}).^33,46,48,55,63--65,67--71,73--86,88--90,92,94--97^ As shown in Figure [1](#ags312208-fig-0001){ref-type="fig"}, the visual field differed depending on the approach of the anastomotic device, and the left upper abdomen provided the widest visual field of the anastomotic plane.

###### 

Summary reported of esophagojejnostomy insertion site of circular staler n (%)

  Authors            Nation          Method                                              No. of patients                                     Leakage                                             Stricture                                            Year
  ------------------ --------------- --------------------------------------------------- --------------------------------------------------- --------------------------------------------------- ---------------------------------------------------- ------
  Left upper                                                                                                                                                                                                                                          
  Omori T^77^        Japan           DST                                                 10                                                  0 (0)                                               0 (0)                                                2009
  Sakuramoto S^85^   Japan           Orvil                                               24                                                  0 (0)                                               0 (0)                                                2010
  Jung YJ^48^        Korea           Orvil                                               40                                                  2 (5)                                               1 (2.5)                                              2013
  Du J^69^           China           SST                                                 52                                                  0 (0)                                               0 (0)                                                2014
  Muguruma K^78^     Japan           DST                                                 32                                                  0 (0)                                               0 (0)                                                2014
  Hiyoshi Y^92^      Japan           Orvil                                               21                                                  2 (9.5)                                             0 (0)                                                2014
  Kwon Y^94^         Korea           Orvil                                               36                                                  1 (2.8)                                             2 (5.6)                                              2014
  Ichikawa D^63^     Japan           DST & Orvil                                         86                                                  0 (0)                                               3 (3.5)                                              2015
  Yamada T^73^       Japan           SST                                                 10                                                  0 (0)                                               0 (0)                                                2015
  Lu X^95^           China           Orvil                                               25                                                  0 (0)                                               0 (0)                                                2016
  Liu W^76^          china           SST                                                 41                                                  0 (0)                                               0 (0)                                                2017
  Total              379             5 (1.3)[\*](#ags312208-note-0003){ref-type="fn"}    6 (1.6)[\*](#ags312208-note-0003){ref-type="fn"}                                                                                                             
  Left lower                                                                                                                                                                                                                                          
  Kachikwu EL^86^    United States   Orvil                                               16                                                  0 (0)[\*](#ags312208-note-0003){ref-type="fn"}      3 (18.8)[\*](#ags312208-note-0003){ref-type="fn"}    2011
  Lee JH^33^         South Korea     SST                                                 79                                                  2 (2.5)[\*](#ags312208-note-0003){ref-type="fn"}    0 (0)[\*](#ags312208-note-0003){ref-type="fn"}       2012
  Kim HI^67^         South Korea     SST                                                 36                                                  0 (0)[\*](#ags312208-note-0003){ref-type="fn"}      0 (0)[\*](#ags312208-note-0003){ref-type="fn"}       2013
  Kim JH^80^         Korea           DST                                                 58                                                  0 (0)[\*](#ags312208-note-0003){ref-type="fn"}      1 (1.7)[\*](#ags312208-note-0003){ref-type="fn"}     2015
  Wang H^81^         China           DST & Orvil                                         84                                                  1 (1.2)[\*](#ags312208-note-0003){ref-type="fn"}    4 (4.8)[\*](#ags312208-note-0003){ref-type="fn"}     2015
  Amisaki M^74^      Japan           SST                                                 10                                                  0 (0)[\*](#ags312208-note-0003){ref-type="fn"}      0 (0)[\*](#ags312208-note-0003){ref-type="fn"}       2016
  Ali B^82^          Korea           DST                                                 58                                                  3 (5.2)[\*](#ags312208-note-0003){ref-type="fn"}    5 (8.6)[\*](#ags312208-note-0003){ref-type="fn"}     2017
  Okuno K^75^        Japan           SST                                                 94                                                  0 (0)[\*](#ags312208-note-0003){ref-type="fn"}      2 (2.1)[\*](#ags312208-note-0003){ref-type="fn"}     2017
  Total              435             6 (1.4)[\*](#ags312208-note-0003){ref-type="fn"}    15 (3.4)[\*](#ags312208-note-0003){ref-type="fn"}                                                                                                            
  Umbilical                                                                                                                                                                                                                                           
  Usui S^64^         Japan           SST                                                 15                                                  0 (0)[\*](#ags312208-note-0003){ref-type="fn"}      0 (0)[\*](#ags312208-note-0003){ref-type="fn"}       2008
  Jeong O^84^        South Korea     Orvil                                               16                                                  0 (0)[\*](#ags312208-note-0003){ref-type="fn"}      0 (0)[\*](#ags312208-note-0003){ref-type="fn"}       2009
  Kinoshita T^65^    Japan           SST                                                 10                                                  0 (0)[\*](#ags312208-note-0003){ref-type="fn"}      0 (0)[\*](#ags312208-note-0003){ref-type="fn"}       2010
  Kunisaki C^46^     Japan           Orvil                                               30                                                  1 (3.3)[\*](#ags312208-note-0003){ref-type="fn"}    0 (0)[\*](#ags312208-note-0003){ref-type="fn"}       2011
  Yoshikawa T^68^    Japan           SST                                                 20                                                  0 (0)[\*](#ags312208-note-0003){ref-type="fn"}      0 (0)[\*](#ags312208-note-0003){ref-type="fn"}       2013
  Liao GQ^88^        China           Orvil                                               21                                                  1 (4.8)[\*](#ags312208-note-0003){ref-type="fn"}    1 (4.8)[\*](#ags312208-note-0003){ref-type="fn"}     2013
  Xie JW^89^         China           Orvil                                               28                                                  0 (0)[\*](#ags312208-note-0003){ref-type="fn"}      0 (0)[\*](#ags312208-note-0003){ref-type="fn"}       2013
  Zuiki T^90^        Japan           Orvil                                               52                                                  1 (1.9)[\*](#ags312208-note-0003){ref-type="fn"}    11 (21)[\*](#ags312208-note-0003){ref-type="fn"}     2013
  Zhao YL^79^        China           DST                                                 26                                                  0 (0)[\*](#ags312208-note-0003){ref-type="fn"}      0 (0)[\*](#ags312208-note-0003){ref-type="fn"}       2014
  Matsuda T^70^      Japan           SST                                                 21                                                  1 (4.8)[\*](#ags312208-note-0003){ref-type="fn"}    1 (4.8)[\*](#ags312208-note-0003){ref-type="fn"}     2015
  Kosuga T^71^       Japan           SST & DST                                           136                                                 9 (6.6)[\*](#ags312208-note-0003){ref-type="fn"}    17 (12.5)[\*](#ags312208-note-0003){ref-type="fn"}   2015
  Brenkman HJ^96^    Nertherlands    Orvil                                               47                                                  6 (12.8)[\*](#ags312208-note-0003){ref-type="fn"}   11 (23.4)[\*](#ags312208-note-0003){ref-type="fn"}   2016
  Shida A^97^        Japan           Orvil                                               100                                                 4 (4.0)[\*](#ags312208-note-0003){ref-type="fn"}    4 (4.0)[\*](#ags312208-note-0003){ref-type="fn"}     2016
  Li X^83^           China           DST & Orvil                                         43                                                  1 (2.3)[\*](#ags312208-note-0003){ref-type="fn"}    1 (2.3)[\*](#ags312208-note-0003){ref-type="fn"}     2017
  Yasukawa D^55^     Japan           Orvil                                               51                                                  2 (3.9)[\*](#ags312208-note-0003){ref-type="fn"}    0 (0)[\*](#ags312208-note-0003){ref-type="fn"}       2017
  Total              616             26 (4.2)[\*](#ags312208-note-0003){ref-type="fn"}   46 (7.5)[\*](#ags312208-note-0003){ref-type="fn"}                                                                                                            

DST, double stapling technique; SST, single?stapling technique.

Orvil, Medtronic plc, Dublin, Ireland.

*P* \< 0.05 (Chi‐square test).

John Wiley & Sons, Ltd

![Different approaches of a circular stapler by insertion site. The visual field of the anastomotic plane differs depending on the approach](AGS3-3-14-g001){#ags312208-fig-0001}

Results showed that the occurrence rates of anastomotic leakage and stricture were the lowest in the upper left abdomen approach, and anastomotic complications were significantly higher in a midline umbilical approach. These results suggested that a good visual field may reduce anastomotic complications, and surgeons should be particularly attentive to maintaining a good visual field for the anastomotic plane, even in the umbilical approach, and avoiding unnecessary tension during anastomosis.

The flexible laparoscope should be useful in obtaining a good view where a straightforward view is difficult. However, only a few reports were confirmed to use the flexible laparoscope in each approach; therefore, it is not yet clear whether these complications can be reduced by the use of a flexible scope.

6. CONCLUSION {#ags312208-sec-0006}
=============

We reviewed several recent reports on lymphadenectomy and reconstruction in LTG. As cancers located at the upper third of the stomach and at the esophagogastric junction have increased in recent years,[100](#ags312208-bib-0100){ref-type="ref"} in the future, safe and secure LTG is important. According to the Japanese gastric cancer treatment guidelines, LTG for clinical stage I gastric cancer may be carried out; however, it is recommended that the procedure be conducted under the guidance of experienced surgeons. In contrast, LTG has been rated by the guidelines of the Japan Society for Endoscopic Surgery (2014) as recommendation C1 (may be considered for a patient in need of total gastrectomy, but no scientific evidence in support of the procedure is currently available). Those who consider challenging the procedure should plan to do so with sufficient caution as postoperative complications were reported to occur significantly more often in the first year of its introduction.[24](#ags312208-bib-0024){ref-type="ref"}

Concerning advanced cancer, a Korean group has launched a large multi‐institutional clinical study for prognostic evaluation of lymph node dissection in LTG for advanced gastric cancer (KLASS‐06). LTG for advanced gastric cancer should be carried out on a trial basis until the definitive results are available, and surgeons should be particularly attentive to nodes No. 10 and 11d in a lymphadenectomy without lessening the quality of lymph node dissection compared with OTG.

Then again, inappropriate reconstruction sometimes results in postoperative complications, some of which have recently been reported to correlate with poor long‐term oncological outcome.[101](#ags312208-bib-0101){ref-type="ref"}, [102](#ags312208-bib-0102){ref-type="ref"} In that sense, surgeons must give scrupulous attention to leakage and stricture after EJS while understanding the advantages and disadvantages of each anastomotic device and approach.
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